Conavi Medical Corp. grants 1.6 million stock options to officers
2 reports, 1 independent
Updated Mon 00:00
Still developing
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Conavi Medical Corp. announced that it granted an aggregate of 1,600,000 stock options to its officers under its Omnibus Equity Incentive Plan. The options are exercisable at a price of C$0.20 per common share and are set to vest over four years. Conavi Medical Corp. is a medical device company that designs, manufactures, and markets imaging technologies for minimally invasive cardiovascular procedures.
Why it matters
The grant of stock options is part of the company's compensation structure for its officers. Conavi Medical Corp. specializes in hybrid imaging systems that have received 510(k) clearance from the U.S. Food and Drug Administration.
Who's involved
- TorontoLocation where Conavi Medical Corp. made the announcement
Keep exploring
The entities involved
-
Toronto
capital and largest city of the province of Ontario, Canada